-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0398_06-17-2008.pdf
January 01, 2008 - Although both
tests are easy to perform, there are some limitations to using these traditional laboratory indicators
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/radiotherapy-proton-beam_research.pdf
May 01, 2012 - Proton beam radiotherapy is a form of external beam radiation
that offers better precision for localized dosage than other types
of external beam radiotherapy. Because proton beams deposit
most of their energy during the final portion of their trajectory,
they diminish the risk of damage to tissue surrounding the t…
-
effectivehealthcare.ahrq.gov/sites/default/files/ch_5-user-guide-to-ocer_130129.pdf
January 01, 2012 - 59
Abstract
This chapter discusses considerations for comparator selection in observational comparative effectiveness
research (CER). Comparison groups should reflect clinically meaningful choices in real world practice
and be chosen based on the study question being addressed. Recognizing the implications and pote…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoarthritis-pain_research-protocol.pdf
August 05, 2010 - Evidence Report on the
Source: www.effectivehealthcare.ahrq.gov
Published Online: August 05, 2010
Evidence-based Practice Center Systematic Review Protocol
Project Title: Comparative Effectiveness and Safety of
Analgesics for Osteoarthritis – An Update to the 2006 Report
I. Background and Objectives f…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-drugs-utilization_research.pdf
January 01, 2011 - Utilization of anticancer biologic products among
Medicare beneficiaries, by diagnostic cancer subchapter,
2006-2009
Anticancer Biologics Data Points #7
Fewer than 50 percent of
beneficiaries with bevacizumab
orders had a cancer diagnosis
in the prior 6 months. This was
driven by the biologic’s off-label
use …
-
effectivehealthcare.ahrq.gov/sites/default/files/comparator-selection-in-observational-chapter-5.pptx
January 01, 2013 - Slide 1
Comparator Selection in Observational Comparative Effectiveness Research
Prepared for:
Agency for Healthcare Research and Quality (AHRQ)
www.ahrq.gov
Comparator Selection in Observational Comparative Effectiveness Research
This slide set is based on a user guide titled Developing a Protocol for Observation…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/recombinant-factor-viia_executive.pdf
May 01, 2010 - Layout 1
Background
This report evaluates the level of evidence
currently available to support the
effectiveness and safety of using
recombinant activated coagulation factor
VII (rFVIIa) for clinical indications not
approved by the U. S. Food and Drug
Administration (FDA). rFVIIa is approved
for a variety of uses i…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/rfviia.pptx
May 01, 2010 - Refining Key Questions: Interactive Case Study Quiz
Comparative Effectiveness of Recombinant Factor VIIa for Off-Label Uses vs. Usual Care in the Hospital Setting
Prepared for:
Agency for Healthcare Research and Quality (AHRQ)
www.ahrq.gov
Comparative Effectiveness of Recombinant Factor VIIa for Off-Label Uses vs.…
-
effectivehealthcare.ahrq.gov/sites/default/files/rfviia.pptx
May 01, 2010 - Refining Key Questions: Interactive Case Study Quiz
Comparative Effectiveness of Recombinant Factor VIIa for Off-Label Uses vs. Usual Care in the Hospital Setting
Prepared for:
Agency for Healthcare Research and Quality (AHRQ)
www.ahrq.gov
Comparative Effectiveness of Recombinant Factor VIIa for Off-Label Uses vs.…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-prognostic_methods.pdf
July 01, 2012 - prognostic test.1,3
Step 3: Selecting Studies and Assessing Quality
Previous reviews of prognostic indicators … How were previously established prognostic indicators or other prognostic assessments included in the … Were any previously established prognostic indicators or prediction models being used as comparators … Reviewers need to be aware of any previously established prognostic indicators
that should be included … • A large number of published reports focus on the associations between prognostic
indicators and
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0765-150129.pdf
November 03, 2014 - Topic 0613 Tympanostomy Tubes NSD FINAL
Tympanostomy Tubes in Children
Nomination Summary Document
Results of Topic Selection Process & Next Steps
§ Th…
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-238-cervical-ripening-appendix-e-1.xlsx
January 01, 2009 - Appendix E-1
Appendix E-1. Data Abstraction of Study Characteristics
Table E-1-1
Table E-1-1. Study characteristics of RCTs addressing Key Questions 1 and 2
Key Question Author, Year
Country
Quality Rating Demographics and Baseline Characteristics Other Population Characteristics Reason fo…
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-244-safety-vaccines-update-evidence-summary.pdf
May 01, 2021 - CER 244 Evidence Summary: Safety of Vaccines Used for Routine Immunization in the United States: An Update
Comparative Effectiveness Review
Number 244
Safety of Vaccines Used for Routine
Immunization in the United States: An Update
Evidence Summary
Main Points
Background and Purpose
Considere…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/stem-cell-children_executive.pdf
February 01, 2012 - 1
Comparative Effectiveness Review
Number 48
Hematopoietic Stem-Cell Transplantation in the
Pediatric Population
Executive Summary
Background
Hematopoietic stem-cell transplantation
(HSCT) refers to a procedure in which
hematopoietic progenitor cells, including
repopulating stem cells, are infused
to restore …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/recombinant-factor-viia_disposition-comments.pdf
June 01, 2010 - Evidence-based Practice Center Systematic Review Protocol
Source: www.effectivehealthcare.ahrq.gov
Published Online: June 1, 2010
Comparative Effectiveness Research Review Disposition of Comments Report
Research Review Title: Comparative Effectiveness of In-Hospital Use of Recombinant Factor VIIa…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-234-headaches-pregnancy-summary.pdf
November 01, 2020 - Comparative Effectiveness Review No. 234 Evidence Summary: Management of Primary Headaches in Pregnancy
Comparative Effectiveness Review
Number 234
Management of Primary Headaches
in Pregnancy
Evidence Summary
Main Points
• Prevention of primary headache in women who are pregnant (or attempting to
become pre…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/public-reporting-cost-measures_research-protocol.pdf
January 13, 2014 - Traditionally, indicators related to the quality of healthcare are measured
through various indicators … //myvbch.org/about-vbch/facilities/report-cards/
Washington State Hospital
Association - Quality Indicators … www.wicheckpoint.org/reports_step1.aspx
WHA Information Center -
Wisconsin Inpatient Hospital
Quality Indicators
-
effectivehealthcare.ahrq.gov/sites/default/files/selecting-evidence-quiz.ppt
May 29, 2025 - Quantitative Synthesis II: Interactive Quiz
When To Select Observational Studies
Interactive Quiz
Prepared for:
The Agency for Healthcare Research and Quality (AHRQ)
Training Modules for Systematic Reviews Methods Guide
www.ahrq.gov
When To Select Observational Studies Interactive Quiz
When should observational …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/selecting-evidence-quiz.ppt
May 29, 2025 - Quantitative Synthesis II: Interactive Quiz
When To Select Observational Studies
Interactive Quiz
Prepared for:
The Agency for Healthcare Research and Quality (AHRQ)
Training Modules for Systematic Reviews Methods Guide
www.ahrq.gov
When To Select Observational Studies Interactive Quiz
When should observational …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/progestogens-preterm-birth_executive.pdf
September 01, 2012 - 1
Comparative Effectiveness Review
Number 74
Progestogens for Prevention
of Preterm Birth
Executive Summary
Introduction
Burden of Preterm Birth
Birth before completion of 37 weeks of
pregnancy is considered preterm. These
early births are associated with more
than 85 percent of all perinatal morbidity
an…